The non-hepatic GSTP1 isotype is abundantly expressed in some cancers and may be responsible for anticancer drug resistance by deactivating electrophilic drugs or by influencing cell signaling pathways (reviewed in Reference [164]). The gene discussed is GSTP1; the disease is cancer.